Skip to main content
CPHD logo

Cepheid (CPHD) Stock Analysis

DELISTED 2016

What happened to Cepheid (CPHD) stock?

Cepheid (CPHD) no longer trades on public markets. It was delisted in November 2016. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
Delisting date:
November 2016
Last recorded price (historical):
$52.95 (last quote on record before the November 2016 delisting; historical, not a current quote)
Vol: 2.65M|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Cepheid (CPHD). Cepheid (CPHD) develops, manufactures, and markets molecular diagnostic systems and tests, primarily focusing on rapid and accurate solutions for infectious diseases.

Last analyzed: Jun 15, 2026
Cepheid (CPHD) develops, manufactures, and markets molecular diagnostic systems and tests, primarily focusing on rapid and accurate solutions for infectious diseases. The company leverages its established GeneXpert systems to generate recurring revenue, while navigating industry challenges such as pricing pressures and intense competition.

Cepheid (CPHD) Healthcare & Pipeline Overview

Model self-rating on this text: 69% (not a measure of the evidence) Updated: Jun 15, 2026

More about this archive record

Can I still buy CPHD shares?

No. CPHD stopped trading on public markets in November 2016, so the shares are not available through a broker. Anything you see quoted for CPHD elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before CPHD stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Cepheid. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.